Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT

P.M. Burger, Deepak L. Bhatt, Toni McCabe et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2024

Cited by 5